Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Vididencel by Mendus for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia): Likelihood of Approval
Vididencel is under clinical development by Mendus and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)....
Data Insights
Vididencel by Mendus for Myelodysplastic Syndrome: Likelihood of Approval
Vididencel is under clinical development by Mendus and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase II...